Dyspnea as the major driver of anxiety in amyotrophic lateral sclerosis

C. Morelot-Panzini, T. Perez, H. Gilet, B. Aguilaniu, B. Arnould, P. Devillier, K. Sedkaoui, T. Similowski (Paris, Lille, Lyon, Grenoble, Suresnes, France)

Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Session: Multidimensional analysis of respiratory problems
Session type: Thematic Poster Session
Number: 2190
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Morelot-Panzini, T. Perez, H. Gilet, B. Aguilaniu, B. Arnould, P. Devillier, K. Sedkaoui, T. Similowski (Paris, Lille, Lyon, Grenoble, Suresnes, France). Dyspnea as the major driver of anxiety in amyotrophic lateral sclerosis. Eur Respir J 2014; 44: Suppl. 58, 2190

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute effects in cough flow and chest wall volume after breath-stacking maneuver in amyotrophic lateral sclerosis (ALS)
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

Negative correlation between respiratory drive and SNIP in amyotrophic lateral sclerosis
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014

Upper airway dysfunction in amyotrophic lateral sclerosis
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015

Mood's state, illness behaviour and quality of life in COPD and CHF patients with comparable functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Psychosocial morbidity but not clinical control is associated with dysfunctional breathing in moderate and severe asthmatics
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Multidimensional evaluation of dyspnea in COPD: An observational field-study
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis
Source: Eur Respir J 2010; 35: 353-360
Year: 2010



Lung function and respiratory muscle strength in amyotrophic lateral sclerosis
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015

Supine abdominal contribution: Index of diaphragmatic weakness (DW) in amyotrophic lateral sclesoris (ALS)
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016

The prognostic role of OSA at the onset of amyotrophic lateral sclerosis
Source: Annual Congress 2013 –Long-term NIV: children, neuromuscular patients and technical aspects
Year: 2013

Outcome of non-invasive ventilatory support for acute respiratory failure in amyotrophic lateral sclerosis
Source: Eur Respir J 2007; 30: Suppl. 51, 316s
Year: 2007

Measurement of vital capacity in amyotrophic lateral sclerosis – Forced and slowly performed
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

Acute respiratory failure in amyotrophic lateral sclerosis: management with non-invasive respiratory aids
Source: Eur Respir J 2004; 24: Suppl. 48, 314s
Year: 2004

Autonomic dysregulation; a mechanism of asthma death
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014

Inspiratory muscle training: Resistance to fatigue and functional outcomes during ehxaustive exercise in healthy human
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014

Prognostic value of iterative lung function testing in amyotrophic lateral sclerosis (ALS)
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013


Therapeutic impact of transcutaneous CO2 (TcCO2) nocturnal monitoring and polysomnography in amyotrophic lateral sclerosis (ALS)
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014


Evaluation of the respiratory function in a population with mild/moderate Parkinson's disease
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014

Heart rate recovery after pulmonary rehabilitation is associated with improvement of autonomic nervous system, quality of life and daily physical activity
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014

Respiratory function monitoring in amyotrophic lateral sclerosis patients: 1-year analysis
Source: Virtual Congress 2021 – New insights into lung function testing
Year: 2021